Under liquidation, owners and financials
CVR: 40381015
DKK -265,330
Gross profit
Net result: DKK -265,257
Klokken Aarhus Inc. (100%)
CVR · view owners
Niels Løber
CVR · view management
Under liquidation
Founded 26 March 2019
CVR · view overview
0 employees
Annual report 2025 · average
Director registered: Niels Løber
CVR · 25/11/2025
View the full event history
Rangers Pharmaceutical A/S is a Danish company of the type Aktieselskab based in København K, founded in 2019. The company is in liquidation. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Niels Løber. The company is owned by Klokken Aarhus Inc.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092.
Selskabets formål er at dyrke cannabis til medicinsk brug
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -265 t. | -265 t. | 294 t. | 101 t. | 0 | |
| 202401/01/2024 – 31/12/2024 | -90 t. | 1.6 mio. | 406 t. | -50.8 mio. | - | |
| 202301/01/2023 – 31/12/2023 | -232 t. | 1.2 mio. | 421 t. | -52.4 mio. | - | |
| 202201/01/2022 – 31/12/2022 | -1.1 mio. | -53.1 mio. | 555 t. | -53.6 mio. | - | |
| 202101/01/2021 – 31/12/2021 | -2.7 mio. | -2.7 mio. | 59.9 mio. | -533 t. | 0 | |
| 202001/01/2020 – 31/12/2020 | -302 t. | -4.1 mio. | 46 t. | -829 t. | 1 |
Compared to 18 companies in Dyrkning af krydderiplanter, aromaplanter og lægeplanter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorRangers Pharmaceutical A/S is registered in the Danish CVR register with the status Under liquidation.
The CVR number of Rangers Pharmaceutical A/S is 40381015.
Rangers Pharmaceutical A/S is owned by Klokken Aarhus Inc..
The management of Rangers Pharmaceutical A/S consists of Niels Løber.
In 2025, Rangers Pharmaceutical A/S reported a gross profit of DKK -265,330.
Rangers Pharmaceutical A/S had an average of 0 employees in the 2025 financial year according to the annual report.
Rangers Pharmaceutical A/S has published its annual report for 2025. Gross profit came to DKK -265,330, and the net result was DKK -265,257.
On December 30, 2025, Rangers Pharmaceutical A/S entered liquidation.
As of November 25, 2025, Clifford Starke has left the board of directors of Rangers Pharmaceutical A/S.
As of November 25, 2025, Niels Løber is registered as liquidator of Rangers Pharmaceutical A/S.
As of November 25, 2025, Clifford Starke has stepped down as adm. dir. of Rangers Pharmaceutical A/S.
On November 25, 2025, Rangers Pharmaceutical A/S entered liquidation.
As of September 26, 2025, Dany Vaiman has left the board of directors of Rangers Pharmaceutical A/S.
As of September 26, 2025, Michael James Rank has left the board of directors of Rangers Pharmaceutical A/S.
Rangers Pharmaceutical A/S has published its annual report for 2024. Gross profit came to DKK -90,401, and the net result was DKK 1,641,287.
Rangers Pharmaceutical A/S has published its annual report for 2023. Gross profit came to DKK -232,315, and the net result was DKK 1,244,777.
As of November 7, 2023, Dany Vaiman has joined the board of directors of Rangers Pharmaceutical A/S.
As of November 7, 2023, Michael James Rank has joined the board of directors of Rangers Pharmaceutical A/S.
As of November 7, 2023, Farhan Lalani has left the board of directors of Rangers Pharmaceutical A/S.
As of November 7, 2023, Selcuk Copkayaoglu has left the board of directors of Rangers Pharmaceutical A/S.
As of October 1, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Rangers Pharmaceutical A/S.
As of October 1, 2023, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Rangers Pharmaceutical A/S.
Rangers Pharmaceutical A/S has published its annual report for 2022. Gross profit came to DKK -1,123,696, and the net result was DKK -53,111,223.
Rangers Pharmaceutical A/S has published its annual report for 2021. Gross profit came to DKK -2,731,822, and the net result was DKK -2,726,374.
As of March 24, 2022, Farhan Lalani has joined the board of directors of Rangers Pharmaceutical A/S.
As of March 24, 2022, Clifford Starke is registered as adm. dir. of Rangers Pharmaceutical A/S.
As of March 24, 2022, Farhan Lalani has stepped down as director of Rangers Pharmaceutical A/S.
As of March 23, 2022, Farhan Lalani has left the board of directors of Rangers Pharmaceutical A/S.
Rangers Pharmaceutical A/S has published its annual report for 2020. Gross profit came to DKK -301,553, and the net result was DKK -4,065,623.
As of November 1, 2021, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of Rangers Pharmaceutical A/S.
As of November 1, 2021, Clifford Starke has joined the board of directors of Rangers Pharmaceutical A/S.
As of November 1, 2021, Farhan Lalani has joined the board of directors of Rangers Pharmaceutical A/S.
As of November 1, 2021, Selcuk Copkayaoglu has joined the board of directors of Rangers Pharmaceutical A/S.
As of November 1, 2021, Michael Christian Torben Serring has stepped down as liquidator of Rangers Pharmaceutical A/S.
On November 1, 2021, Rangers Pharmaceutical A/S exited liquidation.
As of October 25, 2021, Farhan Lalani is registered as director of Rangers Pharmaceutical A/S.
As of September 16, 2021, Michael Christian Torben Serring is registered as liquidator of Rangers Pharmaceutical A/S.
On September 16, 2021, Rangers Pharmaceutical A/S entered liquidation.
As of August 18, 2021, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Rangers Pharmaceutical A/S.
As of August 18, 2021, Clifford Starke has left the board of directors of Rangers Pharmaceutical A/S.
As of August 18, 2021, Selcuk Copkayaoglu has left the board of directors of Rangers Pharmaceutical A/S.
As of August 18, 2021, Thileepan Ananthakumaran has left the board of directors of Rangers Pharmaceutical A/S.
As of August 18, 2021, Clifford Starke has stepped down as director of Rangers Pharmaceutical A/S.
As of October 27, 2020, Clifford Starke has joined the board of directors of Rangers Pharmaceutical A/S.
As of October 27, 2020, Thileepan Ananthakumaran has joined the board of directors of Rangers Pharmaceutical A/S.
As of October 27, 2020, Clifford Starke is registered as director of Rangers Pharmaceutical A/S.
As of October 26, 2020, Clifford Starke has left the board of directors of Rangers Pharmaceutical A/S.
As of October 22, 2020, Heinz Kvottrup Lorentzen has left the board of directors of Rangers Pharmaceutical A/S.
As of October 22, 2020, Peter Møller Lassen has left the board of directors of Rangers Pharmaceutical A/S.
As of October 22, 2020, Peter Møller Lassen has stepped down as director of Rangers Pharmaceutical A/S.
Rangers Pharmaceutical A/S has published its interim report for the period March 26, 2019 – December 31, 2019.
As of February 7, 2020, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of Rangers Pharmaceutical A/S.
As of February 7, 2020, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Rangers Pharmaceutical A/S.
As of February 7, 2020, Heinz Kvottrup Lorentzen has joined the board of directors of Rangers Pharmaceutical A/S.
As of February 7, 2020, Peter Møller Lassen has joined the board of directors of Rangers Pharmaceutical A/S.
As of February 7, 2020, Thileepan Ananthakumaran has left the board of directors of Rangers Pharmaceutical A/S.
As of February 7, 2020, Peter Møller Lassen is registered as director of Rangers Pharmaceutical A/S.
As of February 7, 2020, Morten Nøhr Mortensen has stepped down as adm. dir. of Rangers Pharmaceutical A/S.
As of December 2, 2019, Thileepan Ananthakumaran has joined the board of directors of Rangers Pharmaceutical A/S.
As of December 2, 2019, Selcuk Copkayaoglu has joined the board of directors of Rangers Pharmaceutical A/S.
As of December 2, 2019, John Lindsay Joseph McKenna has left the board of directors of Rangers Pharmaceutical A/S.
As of December 2, 2019, Dmitry Zaytsev has left the board of directors of Rangers Pharmaceutical A/S.
As of November 28, 2019, Clifford Starke has joined the board of directors of Rangers Pharmaceutical A/S.
As of November 28, 2019, Jakob Schilder-Knudsen has left the board of directors of Rangers Pharmaceutical A/S.
As of March 26, 2019, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Rangers Pharmaceutical A/S.
As of March 26, 2019, Jakob Schilder-Knudsen has joined the board of directors of Rangers Pharmaceutical A/S.
As of March 26, 2019, John Lindsay Joseph McKenna has joined the board of directors of Rangers Pharmaceutical A/S.
As of March 26, 2019, Dmitry Zaytsev has joined the board of directors of Rangers Pharmaceutical A/S.
As of March 26, 2019, Morten Nøhr Mortensen is registered as adm. dir. of Rangers Pharmaceutical A/S.
As of March 26, 2019, is registered as an owner of Rangers Pharmaceutical A/S with an ownership share of 100%.
Rangers Pharmaceutical A/S was founded on March 26, 2019.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
